Navigation Links
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Date:5/19/2009

clude, among other things, statements regarding clinical trials, regulatory approvals, competitive offerings and product performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to al
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
2. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
3. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
4. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
5. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
6. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
7. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
8. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
9. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
10. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
11. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 3, 2015 Today, the ... Internet. As markets become ever more transparent, the importance ... AG recognised long ago. Its maxim of "innovation brings ... networking and digitisation. The company has long ... "state of the art" technology and modern approach, while ...
(Date:6/2/2015)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... of products for the treatment of central nervous system ... M.D., Vanda,s President and CEO, will deliver a corporate ... New York City on Thursday, June ... The presentation at the Jefferies Global Healthcare Conference will ...
(Date:6/2/2015)... N.C. , June 2, 2015 Kewaunee ... Board of Directors declared a quarterly cash dividend of ... 2015 to stockholders of record at the close of ... Kewaunee Scientific Founded in 1906, Kewaunee Scientific ... manufacture, and installation of laboratory, healthcare, and technical furniture ...
Breaking Medicine Technology:
... Sweden, September 1 Calabar AB, a privately,held ... announced a EUR 350,000 equity financing from the ... Calabar,s product,through a phase II study with repeated ... drug on the minor glands will lead to ...
... 1 Biosensors,International Group, Ltd ("Biosensors", "Company"), ... drug-eluting stent,developed by Biosensors, has demonstrated equal ... Johnson,s industry leading drug-eluting stent, CYPHER,SELECT(TM) ("Cypher"), ... The results of the landmark study were ...
Cached Medicine Technology:Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 3
(Date:6/3/2015)... These are challenging and unpredictable times for ... of digital-first business are rewriting the rules for business ... need for traditional businesses to take on a more ... their services. On top of this there is ... start-ups, to bring new innovation and approaches to business. ...
(Date:6/3/2015)... First Choice Emergency Room , ... the United States, announced that it is opening its ... , “I am pleased to announce that we ... facility in the San Antonio area,” said Dr. James ... Room. , First Choice Emergency Room is revolutionizing ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
(Date:6/3/2015)... 03, 2015 Foot and Ankle ... Casey Friske ( Clarksville Division ) was recently ... Symposium of Advanced Wound Care (SAWC) and the American ... Dan Davis. The Conference was held on April ... Center in San Antonio, TX. , Dr. Casey ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Veatch Consulting ... Satisfaction. Since they first opened for business in April ... service the needs of their clients. Each and every ... Veatch Dental Consulting is proud to say that they ... , A new feature recently added this year is ...
Breaking Medicine News(10 mins):Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3
... ... ... ... ...
... NC A novel technology for delivering nicotine to the ... the habit. When compared to the nicotine vapor ... proved more effective at delivering nicotine to the blood stream. ... according to Duke University Medical Center researchers. Users also reported ...
... against trying on your own , SATURDAY, Feb. ... way for children with serious peanut allergies, with two ... kids, tolerance over time. , Both studies were small, ... on peanut-allergic children whose immune systems were prompted to ...
... ... faculty and staff, a seven-member team of community college administrators from across ... for GateWay Community College. The news was announced at an exit meeting ... Rebecca Nickoli talked of how the team saw firsthand the college,s "engagement ...
... ... addition of Garrett and Sylvia McGrath, top earners in the network marketing industry and ... ... -- EvolvHealth LLC http://EvolvHealth.com announced today the addition of Garrett and Sylvia ...
... ... ... , , ... ...
Cached Medicine News:Health News:American Red Cross Responds Internationally and at Home to Chile Quake 2Health News:American Red Cross Responds Internationally and at Home to Chile Quake 3Health News:American Red Cross Responds Internationally and at Home to Chile Quake 4Health News:American Red Cross Responds Internationally and at Home to Chile Quake 5Health News:American Red Cross Responds Internationally and at Home to Chile Quake 6Health News:New smoking cessation therapy proves promising 2Health News:Kids' Peanut Allergies Might Be Tamed: Study 2Health News:Kids' Peanut Allergies Might Be Tamed: Study 3Health News:Kids' Peanut Allergies Might Be Tamed: Study 4Health News:GateWay Community College Receives Strong Endorsement for Re-accreditation 2Health News:GateWay Community College Receives Strong Endorsement for Re-accreditation 3Health News:Why Leading Network Marketers Garrett and Sylvia McGrath Joined EvolvHealth LLC 2Health News:Why Leading Network Marketers Garrett and Sylvia McGrath Joined EvolvHealth LLC 3Health News:Doctors Applaud Latest Furlough Reversal 2Health News:Doctors Applaud Latest Furlough Reversal 3
Designed to lift corneal cap/flap during corneal lamellar surgery...
... Refractive drape has two perforations ... adapts to various single or ... draping. Refractive drape has two ... Drape adapts to various single ...
Unique 2 in 1 design allows simultaneous absorption of excess fluid & protection of flap & hinge, Lint-free PVAmaterial....
Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
Medicine Products: